S48H - Why New Clients May be Asking for Antimicrobial Prescriptions Beginning June 2023 & Adverse Event Reporting of Drugs and Vaccines (Part 2)

Wednesday, February 22, 2023

3:00 PM – 3:50 PM

Location: South Seas F, Level 3

Earn 1 CE Hours

Sponsored By

AMERICAN VETERINARY MEDICAL ASSOCIATION

Presenter(s)

Mike Murphy, DVM, JD, PhD

Director, Division of Animal and Public Health

PDF Handouts

Moderator(s)

Jackie Ott Jaakola

Executive Director
EVERYCAT HEALTH FOUNDATION
Wyckoff, NJ, United States

FDA's GFI # 263 transitioning remaining medically important antimicrobials from over-the-counter (OTC) to prescription drug status goes into effect in June of 2023. This means both companion animal and food-producing animal clients will need a prescription to obtain drugs they have received OTC. USDA's Center for Veterinary Biologics now receives adverse event reports (ADE) on vaccines and other animal biologics. Learn how you can both report ADEs and see what has been reported.

Learning Objectives:

Be familiar with medically important antimicrobials that will transition to prescription marketing status as of June 2023 and understand how veterinarians may be impacted
Know how to report adverse events associated with unapproved new animal drugs, new animal drugs, and animal biologics to FDA and USDA, respectively
Know how to access reports to help protect patient safety